PRILENAL 2.5 MG, TABLETS
PRILENAL 2.5 MG, TABLETS
Not authorised
- Enalapril maleate
Product identification
Medicine name:
PRILENAL 2.5 MG, TABLETS
PRILENAL 2.5MG/TAB ΔΙΣΚΙΟ
Active substance:
- Enalapril maleate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Enalapril maleate2.50/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC09AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Greece
Package description:
- Box containing 4 blisters of 7 tablets
- Box containing 24 blisters of 7 tablets
- Box containing 12 blisters of 7 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Hellas LLC
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva Sante Animale
- EUROPHARTECH
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 3643/19-01-2010/K-0157702
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0152/002
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
